It was found that inhibition of PD-1/PD-L1 function contributes to restoration of T lymphocyte function [19] and promotes the penetration of CD8+ T cells in a mouse model of pancreatic cancer, having a synergistic effect with standard chemotherapy [20] and limiting the spread of melanoma and colorectal cancer in mice [21]. Here, PDCD1 is linked to melanoma.